Back
Arbutus Biopharma Corp. Stock Predictions
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
43
ABUS
Arbutus Biopharma Corp.
Last Price:
$4.62
Seasonality Move:
19.24%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atArbutus Biopharma Corp. Stock Forecast
-
Is Arbutus Biopharma Corp. Stock Undervalued?The current Arbutus Biopharma Corp. [ABUS] share price is $4.62. The Score for ABUS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
ABUS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Arbutus Biopharma Corp. Stock Go Up Next Year?
Data Unavailable
Arbutus Biopharma Corp. Stock Rating
Data Unavailable
Arbutus Biopharma Corp. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
arbutusbio.com
52-Week Data
52-Week High:
5.10
52-Week Low:
2.71
Prediction Charts
Market Cap:
888.5M
Price in USD:
4.62
Volume:
902K
Beta:
1.46
Technical Analysis
SMA50:
4.56
SMA100:
4.37
SMA200:
3.84
52-Wk Change:
37.91%
Stock Predictions
-
Is Arbutus Biopharma Corp. stock public?Yes, Arbutus Biopharma Corp. is a publicly traded company.
-
What is the Arbutus Biopharma Corp. stock quote today?The Arbutus Biopharma Corp. stock price is 4.62 USD today.
-
How to buy Arbutus Biopharma Corp. stock online?You can buy Arbutus Biopharma Corp. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-17 | 4.62 | 4.64 | 4.69 | 4.54 |
| Dec-18 | 4.65 | 4.54 | 4.70 | 4.51 |
| Dec-19 | 4.55 | 4.43 | 4.62 | 4.42 |
| Dec-22 | 4.46 | 4.72 | 4.79 | 4.45 |
| Dec-24 | 4.70 | 4.79 | 4.91 | 4.70 |
| Dec-26 | 4.77 | 4.78 | 4.82 | 4.66 |
| Dec-29 | 4.76 | 4.72 | 4.81 | 4.66 |
| Dec-30 | 4.70 | 4.62 | 4.75 | 4.55 |
| Dec-31 | 4.61 | 4.81 | 5.05 | 4.59 |
| Jan-5 | 4.77 | 4.71 | 4.84 | 4.66 |
| Jan-6 | 4.65 | 4.79 | 4.83 | 4.65 |
| Jan-7 | 4.81 | 4.88 | 5.00 | 4.79 |
| Jan-8 | 4.81 | 4.65 | 4.87 | 4.59 |
| Jan-9 | 4.69 | 4.62 | 4.73 | 4.60 |
Arbutus Biopharma Corp. Earnings
Data Unavailable
Arbutus Biopharma Corp. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.00 per share.
* Arbutus Biopharma Corp. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.